Skip to main content

Adlarity Side Effects

Generic name: donepezil

Medically reviewed by Drugs.com. Last updated on Jan 31, 2025.

Note: This document provides detailed information about Adlarity Side Effects associated with donepezil. Some dosage forms listed on this page may not apply specifically to the brand name Adlarity.

Applies to donepezil: transdermal patch extended release.

Other dosage forms:

Serious side effects of Adlarity

Along with its needed effects, donepezil (the active ingredient contained in Adlarity) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking donepezil:

More common side effects

  • diarrhea
  • nausea
  • vomiting

Less common side effects

  • aggressive, angry
  • back pain
  • bleeding gums
  • blurred vision
  • chest pain
  • confusion
  • coughing up blood
  • decreased urination
  • difficulty in breathing or swallowing
  • discouragement
  • dizziness
  • dry mouth
  • fainting
  • feeling sad or empty
  • headache
  • increase in heart rate
  • increased menstrual flow or vaginal bleeding
  • irritability
  • lack of appetite
  • lightheadedness
  • loss of bladder control
  • loss of interest or pleasure
  • nervousness
  • nosebleeds
  • paralysis
  • pounding in the ears
  • prolonged bleeding from cuts
  • rapid breathing
  • red or dark brown urine
  • red or black, tarry stools
  • seeing, hearing, or feeling things that are not there
  • sleepiness or unusual drowsiness
  • slow or fast heartbeat
  • sunken eyes
  • thirst
  • trouble concentrating
  • trouble sleeping
  • unusual tiredness or weakness
  • wrinkled skin

Incidence not known

  • anxiety
  • back, leg, or stomach pains
  • blistering, burning, crusting, dryness, or flaking of the skin where the patch is applied
  • bloating
  • blood in the vomit
  • chest pain, discomfort, or tightness
  • chills
  • coma
  • constipation
  • dark urine
  • fever
  • general body swelling
  • increased thirst
  • indigestion
  • itching, scaling, severe redness, soreness, or swelling of the skin where the patch is applied
  • light-colored stools
  • muscle aches, pain, stiffness, or cramps
  • pains in stomach, side, or abdomen, possibly radiating to the back
  • pale skin
  • seizures
  • severe or continuing stomach pain
  • shaking
  • sore throat
  • sweating
  • swelling of the face, ankles, or hands
  • upper right abdominal or stomach pain
  • vomiting of blood or material that looks like coffee
  • yellowing of the eyes or skin

Get emergency help immediately if any of the following symptoms of overdose occur while taking donepezil:

Symptoms of overdose

Other side effects of Adlarity

Some side effects of donepezil may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common side effects

  • accident
  • bruising
  • large, flat, blue or purplish patches in the skin

For healthcare professionals

Applies to donepezil: oral tablet, oral tablet disintegrating, transdermal film.

General adverse events

The most common adverse events were diarrhea, muscle cramps, fatigue, nausea, vomiting, anorexia and insomnia. Most adverse events are mild in severity and transient in nature.[Ref]

Frequency of common adverse effects may be influenced by the rate of titration.[Ref]

Gastrointestinal

Nervous system

Cardiovascular

Dermatologic

Genitourinary

Metabolic

Musculoskeletal

Ocular

Other

Psychiatric

Respiratory

Endocrine

Hematologic

Hepatic

References

1. (2001) "Product Information. Aricept (donepezil)." Pfizer U.S. Pharmaceuticals

2. Cerner Multum, Inc. "UK Summary of Product Characteristics."

3. Cerner Multum, Inc. "Australian Product Information."

4. Rogers SL, Friedhoff LT (1996) "The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicentre, randomized, double-blind, placebo-controlled trial." Dementia, 7, p. 293-303

5. Lam W (2002) "Pharmacological treatment of cognitive deficits in Alzheimer's disease." Med J Aust, 176, 297; discussion 297-8

6. Mihara M, Ohnishi A, Tomono Y, Hasegawa J, Shimamura Y, Yamazaki K, Morishita N (1993) "Pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy male volunteers." Int J Clin Pharmacol Ther Toxicol, 31, p. 223-9

7. Bourke D (1998) "Possible association between donepezil and worsening Parkinson's disease." Ann Pharmacother, 32, p. 610-11

8. Babic T, Zurak N (1999) "Convulsions induced by donepezil." J Neurol Neurosurg Psychiat, 66, p. 410

9. Amouyal-Barkate K, Bagheri-Charabiani H, Montastruc JL, Moulias S, Vellas B (2000) "Abnormal movements with doneprzil in Alzheimer disease." Ann Pharmacother, 34, p. 1347

10. Miyaoka T, Seno H, Yamamori C, Inagaki T, Itoga M, Tsubouchi K, Horiguchi J (2001) "Pisa syndrome due to a cholinesterase inhibitor (Donepezil): A case report." J Clin Psychiatry, 62, p. 573-4

11. Kawashima T, Yamada S (2002) "Delirium caused by donepezil: a case study." J Clin Psychiatry, 63, p. 250-1

12. Onofrj M, Thomas A (2003) "Severe worsening of parkinsonism in Lewy body dementia due to donepezil." Neurology, 61, p. 1452

13. Rozzini L, Ghianda D, Trabucchi M, Padovani A (2004) "Severe worsening of parkinsonism in Lewy body dementia due to donepezil." Neurology, 63, 1543-4; author reply 1543-4

14. Bryant CA, Ouldred E, Jackson SHD, Kinirons MT (1998) "Drug points: Purpuric rash with donepezil treatment." BMJ, 317, p. 787

15. Hashimoto M, Imamura T, Tanimukai S, Kazui H, Mori E (2000) "Urinary incontinence: an unrecognised adverse effect with donepezil." Lancet, 356, p. 568

16. Iraqi A, Hughes TL (2009) "An unusual case of nightmares with galantamine." J Am Geriatr Soc, 57, p. 565

Frequently asked questions

Further information

Adlarity side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.